Under construction – not a live service

Skip to content

Frontlight Research

Trial site

ICO - Site Paul Papin

Angers, Maine Et Loire, FranceNot linked to an institution yet

2running trials
2closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NCT03143322· Source
Active, not recruiting
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
NCT02811861· Phase 3· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
NCT04495621· Phase 1/2· Source
Completed
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
NCT03734029· Phase 3· Source

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error

Under construction, not live – ICO - Site Paul Papin: trial site – Frontlight Research